| Model Number |
BXA075902A |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/17/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2020 a patient underwent aortic aneurysm treatment within the tambe 1701 clinical study.Two gore® viabahn® vbx balloon expandable endoprosthesis were utilized in the superior mesenteric artery (sma).On (b)(6) 2021 sma stenosis was reported.
|
| |
|
Additional Manufacturer Narrative
|
|
D.10.As it is not known which device was involved, or if both were involved, the following device is also being investigated: bxa075902a sn: (b)(6), udi: (b)(4).
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2020 a patient underwent aortic aneurysm treatment within the tambe 1701 clinical study.Two gore® viabahn® vbx balloon expandable endoprosthesis were utilized in the superior mesenteric artery (sma).On (b)(6) 2020, the mesenteric artery circulation was evaluated with pulse wave doppler and color flow duplex imaging.The sma was found to be patent with normal flow velocities and doppler profile.On (b)(6) 2021 sma stenosis was reported.This was described as hemodynamically significant (>70%).This was treated by means of angioplasty.On (b)(6) 2021 the mesenteric artery circulation was evaluated with pulse wave doppler and color flow duplex imaging.This showed a patent sma with normal flow velocities and doppler profile.
|
| |
|
Additional Manufacturer Narrative
|
|
H.6.Results code 1: 213: a review of the manufacturing records for the device verified the lot met pre-release specifications.
|
| |
|
Additional Manufacturer Narrative
|
|
Added pma/510(k)number.
|
| |
|
Search Alerts/Recalls
|